BSEGeneral▲ PositiveOrder Win30 Oct 2026
Goodluck India Ltd
we are please to inform you that the Goodluck Defence and Aerospace Limited, subsidiary of the Company has received an order of Rs. 58.20 Cr.
Goodluck India Ltd's subsidiary, Goodluck Defence and Aerospace Limited, has received an order worth Rs. 58.20 Cr. for the supply of 155mm HE ERFB (BB) w/Lifting Plug shells.
NSEBagging/Receiving of orders/contracts▲ PositiveOrder Win30 Oct 2026
Goodluck India Limited
Bagging/Receiving of orders/contracts
Goodluck India Limited's subsidiary, Goodluck Defence and Aerospace Limited, has received an order worth Rs. 58.20 Crore for supplying 155mm HE ERFB (BB) w/Lifting Plug shells.
NSEInvestor Presentation▲ PositiveResults30 Oct 2026
Privi Speciality Chemicals Limited
Investor Presentation
Privi Speciality Chemicals Limited has informed the Exchange about Investor Presentation for Q2 & H1 FY27 results, highlighting strong financial performance, resilience of business model, and disciplined execution.
BSECompany Update▲ PositiveResults30 Oct 2026
Privi Speciality Chemicals Ltd
Investor Presentation - Financial & Operational Review for Quarter and half year ended September 30,2026.
Privi Speciality Chemicals Ltd has released its investor presentation for Q2 and H1 FY27, showcasing strong financial performance with a 13.9% year-on-year growth in total income, 16.66% year-on-year growth in EBITDA, and 24.61% year-on-year growth in Net Profit. The company attributes its resilience to its diversified geographic presence and disciplined execution despite adverse global headwinds.
NSEUpdates▲ PositiveOrder Win30 Oct 2026
Acme Solar Holdings Limited
Updates
ACME Solar Holdings Limited has signed a Power Purchase Agreement (PPA) with NTPC Limited for a 400 MW Inter-State Transmission System (ISTS)-connected Firm and Dispatchable Renewable Energy (FDRE) project at a tariff of INR 4.37 per unit.
BSECompany Update▲ PositiveOrder Win30 Oct 2026
ACME Solar Holdings Ltd
ACME Solar signs PPA with NTPC for 400 ISTS connected FDRE Project
ACME Solar Holdings Ltd has signed a Power Purchase Agreement (PPA) with NTPC Limited for a 400 MW Inter-State Transmission System (ISTS)-connected Firm and Dispatchable Renewable Energy (FDRE) project at a tariff of INR 4.37 per unit.
BSECompany Update▲ PositiveExpansion30 Oct 2026
Lords Mark Industries Ltd
Regulation 30 intimation
Lords Mark Industries Ltd announces Regulation 30 intimation titled 'Brahamastra, Part Of Lord's Mark Industries Limited, Takes Indigenous Defence Innovation To The Global Stage'. The company is pursuing an ambitious vision to position India as a global force in indigenous defence technology, with a focus on advancing indigenous defence manufacturing in line with the Atmanirbhar Bharat initiative.
NSEPress Release▲ PositiveExpansion30 Oct 2026
Hikal Limited
Press Release
Hikal Limited's Bengaluru API facility has been granted Swissmedic GMP certification, strengthening its global regulatory standing and expanding access to European and other regulated markets.
BSECompany Update▲ PositiveExpansion30 Oct 2026
Hikal Ltd
Press Release on Hikal''s Bengaluru API facility earns Swissmedic GMP Certification
Hikal Ltd's Bengaluru API facility has received Swissmedic GMP certification, strengthening its global regulatory standing and expanding access to European and other regulated markets.
NSEPress Release▲ PositiveExpansion30 Oct 2026
Sun Pharmaceutical Industries Limited
Press Release
Sun Pharmaceutical Industries Limited has announced that the U.S. FDA has approved ILUMYA (tildrakizumab-asmn) for the treatment of adults with active psoriatic arthritis, expanding the use of ILUMYA beyond moderate-to-severe plaque psoriasis.
BSECompany Update▲ PositiveResults30 Oct 2026
Sun Pharmaceutical Industries Ltd
ILUMYA (tildrakizumab-asmm) approved in the U.S. for the treatment of adults with active Psoriatic Arthritis
Sun Pharmaceutical Industries Ltd announced the US FDA approval of ILUMYA (tildrakizumab-asmm) for the treatment of adults with active Psoriatic Arthritis, expanding the use of ILUMYA beyond moderate-to-severe plaque psoriasis.
BSECompany Update▲ PositiveResults30 Oct 2026
Fabtech Technologies Ltd
Please find attached Investor Presentation in relation to the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half- year ended September 30, 2026.
Fabtech Technologies Ltd has released its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, with revenue and EBITDA (including other income) doubling QoQ to ₹155.7 mn in Q2 FY27, and management confident of achieving its FY27 Adjusted PAT margin objective of 8-9%.
BSECompany Update▲ PositiveExpansion30 Oct 2026
MTAR Technologies Ltd
Investor presentation
MTAR Technologies Ltd presented its investor presentation for October 2026, highlighting its focus on indigenising critical technologies, revenue growth of 80%, and EBITDA margin of 24% ±100 bps. The company aims to build a diversified and resilient business by expanding its product portfolio, increasing wallet share with existing customers, and growing its global customer base.
NSEBagging/Receiving of orders/contracts▲ PositiveOrder Win29 Oct 2026
Tonbo Imaging India Limited
Bagging/Receiving of orders/contracts
Tonbo Imaging India Limited has received a strategic export order from a state-owned company in Europe for the supply of its EO/IR stabilised seeker, valued at approximately EUR 65,000, with an option to place an order for a total potential value of approximately EUR 13 million.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults29 Oct 2026
Adani Total Gas Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Adani Total Gas Limited has announced its Q2 FY '27 earnings, with strong operational performance, 12% year-on-year EBITDA growth, and a resilient execution despite a challenging global energy environment.
NSEAgreements▲ PositiveM&A29 Oct 2026
Krishna Institute of Medical Sciences Limited
Agreements
Krishna Institute of Medical Sciences Limited has entered into definitive agreements to acquire a 51% equity stake in Sarvottam Health Care Private Limited for ₹80.00 crore, with the transfer of shares expected to be completed in due course.
BSECompany Update▲ PositiveResults29 Oct 2026
Adani Total Gas Ltd
Transcript of Earning Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026
Adani Total Gas Ltd reported strong operational performance for the quarter and half year ended September 30, 2026, with Q2 FY '27 volumes growing 12% year-on-year to 315 MMSCM and EBITDA increasing 12% to INR340 crores. For half year ended 30th September 2026, volumes grew 13% to 618 MMSCM and EBITDA rose 3% to INR621 crores.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults29 Oct 2026
DCB Bank Limited
Analysts/Institutional Investor Meet/Con. Call Updates
DCB Bank Limited has announced its Q2 FY27 earnings, with net interest income growing by 17% Y-o-Y, advances growing by 21% Y-o-Y, and deposits growing by 19%. The bank's net profit has risen by 29% over the year to INR 236 crores, the highest ever in a quarter. The bank has also achieved a 7.23% improvement in PCR and a 9.6% improvement in PCR excluding technical write-off.
BSECompany Update▲ PositiveM&A29 Oct 2026
Krishna Institute of Medical Sciences Ltd
The Company ahs entered into definitive agreements for acquiring 51% stake in Sarvottam Healthcare Private Limited
Krishna Institute of Medical Sciences Ltd has entered into definitive agreements to acquire a 51% stake in Sarvottam Health Care Private Limited for ₹80.00 crore. The acquisition is expected to be completed in due course.
BSECompany Update▲ PositiveResults29 Oct 2026
DCB Bank Ltd
Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the transcript of the Earnings Conference Call held on October 23, 2026 with respect to the Unaudited Financial Results of DCB Bank Limited ('the Bank') for the quarter and half year ended September 30, 2026. The same has also been uploaded on website of the Bank and can be accessed at the link given in the letter.
DCB Bank Ltd reported Q2FY27 results with 21% Y-o-Y growth in advances, 19% Y-o-Y growth in deposits, and 17% Y-o-Y growth in net interest income. Net profit rose by 29% over the year to INR 236 crores, the highest ever in a quarter. The bank's ROA and ROE were 1.03% and 14.6% respectively for the quarter, and 1% and 14.12% respectively for the half year.